LEADERS: Lakeshore Examination of Activity and Disability Exercise Response Study

Sponsor
University of Alabama at Birmingham (Other)
Overall Status
Completed
CT.gov ID
NCT02533882
Collaborator
Lakeshore Foundation (Other)
180
1
3
56.9
3.2

Study Details

Study Description

Brief Summary

This study will examine the effectiveness of two types of group exercise classes on the health and functional status in inactive adults age 18-65 with neurological conditions including Multiple Sclerosis, stroke, and spinal cord injury (SCI). Participants will be randomly assigned to one of three groups; Movement to Music, Adapted Yoga, or a waitlist group who will complete a home-based exercise intervention of either Movement to Music or Adapted Yoga.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Movement to Music
  • Behavioral: Adapted Yoga
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
180 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Dose-Response Effects of Transformative Exercise in Improving Health and Function in Adults With Spinal Cord Injury and Multiple Sclerosis
Study Start Date :
Dec 1, 2014
Actual Primary Completion Date :
Jul 15, 2019
Actual Study Completion Date :
Aug 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Movement to Music

The Movement to Music classes are composed of a set of exercises tailored to the specific needs and capabilities of each target group. The class will consist of and aerobic component and a strength component performed to varying music tempos. All movements will be choreographed by qualified dance instructors.

Behavioral: Movement to Music

Active Comparator: Adapted Yoga

Yoga classes will consist of postures adapted by qualified yoga instructors who have extensive experience in disability.

Behavioral: Adapted Yoga

No Intervention: Waitlist Control

This group will receive biweekly newsletters on a variety of topics. At the end of this trial, they will receive a home based intervention.

Outcome Measures

Primary Outcome Measures

  1. Cardiorespiratory Fitness as measured by sub-maximal VO2 [12 weeks]

    Submax VO2 is assessed by the six minute walk test or the six minute push test. Participants wear a portable metabolic cart while walking or pushing

  2. Pain as measured by PROMIS Pain Interference Short Form 8a [12 weeks]

  3. Fatigue as measured by PROMIS Fatigue Short Form 8a [12 weeks]

  4. Loneliness as measured by the Three-Item Loneliness Scale [12 weeks]

  5. Grip Strength as measured by hand grip dynamometer [12 weeks]

  6. Strength as measured by Biodex System 3 Multijoint dynamometer [12 weeks]

    Upper body strength is measured using a closed chain push/pull protocol. Lower body strength is measured using the knee flexion/extension protocol.

  7. Balance as measured by the Timed Up and Go [12 weeks]

    The Timed to Up and Go test is performed using a chair with arms. The participants stand up from the chair, walk to a mark measured three meters from the chair then return back to the seat. A score of greater than or equal to 14 seconds (average) has been shown to indicate a high risk of falling.

  8. Balance as measured by Biodex Limits of Stability [12 weeks]

    The Limits of Stability test is performed on the Biodex SD balance machine using the limits of stability protocol created by Biodex.

  9. Balance as measured by Repeated Chair Stands [12 weeks]

    The repeated chair stands test is performed by asking participants to stand up and sit down 5 times as fast as possible. A score of greater than or equal to 14 seconds (average) has been shown to indicate a high risk of falling.

Secondary Outcome Measures

  1. Health Biomarkers as measured by blood analysis (insulin) [12 weeks]

  2. Health Biomarkers as measured by blood analysis (lipids) [12 weeks]

  3. Health Biomarkers as measured by blood analysis (fasting glucose) [12 weeks]

  4. Blood pressure [12 weeks]

  5. Anthropometric measurements (weight) [12 weeks]

  6. Circumference measurements to be reported as composite ratios (waist circumference, hip circumference, neck circumference) [12 weeks]

  7. Physical Function with Mobility Aid as measured by PROMIS Physical Function with Mobility Aid 455b [12 weeks]

  8. Anxiety as measured by PROMIS Emotional Distress-Anxiety Short Form 8a [12 weeks]

  9. Depression as measured by PROMIS Emotional Distress-Depression Short Form 8a [12 weeks]

  10. Sleep Disturbance as measured by PROMIS Sleep Disturbance Short Form 8a [12 weeks]

  11. Ability to participate in social roles and activities as measured by PROMIS Ability to Participate in Social Roles and Activities Short Form 8a [12 weeks]

  12. Nutrition Self-Efficacy as measured by the Nutrition Self-Efficacy Scale [12 weeks]

  13. Physical Exercise Self-Efficacy as measured by the Physical Exercise Self Efficacy Scale [12 weeks]

  14. PROMIS Pain Intensity Short Form [12 Weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosed with stroke

  • MS - mild to moderate disability (Patient Determined Disease Steps Score 0-6)

  • Able to use arms or arms/legs for exercise

  • Ambulatory or use manual wheelchair

Exclusion Criteria:
  • Cognitive impairment (Mini-Mental State Exam score < 24)

  • Recent weight change (+/- 25 pounds in 1 year)

  • Poorly controlled blood pressure

  • Cardiovascular disease event within the past six months

  • Severe pulmonary disease

  • Renal failure

  • Current tobacco user or quit within the last six months

  • Current use of medications for psychosis

  • Active pressure ulcers

Contacts and Locations

Locations

Site City State Country Postal Code
1 Lakeshore Foundation Birmingham Alabama United States 35209

Sponsors and Collaborators

  • University of Alabama at Birmingham
  • Lakeshore Foundation

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
James Rimmer, Principal Investigator, University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT02533882
Other Study ID Numbers:
  • F140821001
First Posted:
Aug 27, 2015
Last Update Posted:
Oct 15, 2019
Last Verified:
Oct 1, 2019
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 15, 2019